Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies.

Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M.

Lancet. 2007 Oct 20;370(9596):1422-31.

PMID:
17950857
[PubMed - indexed for MEDLINE]
2.

[Therapy of asthma: anti-inflammatory effects of antileukotrienes].

Ukena D.

Med Klin (Munich). 1997 Dec;92 Suppl 5:37-40. doi: 10.1007/BF03041978. Review. German.

PMID:
19479395
[PubMed - indexed for MEDLINE]
3.

Pitrakinra for asthma.

Antoniu SA, Cojocaru I.

Expert Opin Biol Ther. 2010 Nov;10(11):1609-15. doi: 10.1517/14712598.2010.524203. Epub 2010 Oct 5. Review.

PMID:
20923253
[PubMed - indexed for MEDLINE]
4.

[Inflammatory cytokines (IL-4, IL-5 and IL-13)].

Maeda S, Yanagihara Y.

Nihon Rinsho. 2001 Oct;59(10):1894-9. Review. Japanese.

PMID:
11676128
[PubMed - indexed for MEDLINE]
5.

Eosinophils and interleukin-5: the debate continues.

Kay AB, Menzies-Gow A.

Am J Respir Crit Care Med. 2003 Jun 15;167(12):1586-7. Review. No abstract available.

PMID:
12796050
[PubMed - indexed for MEDLINE]
6.

microRNAs in asthma: potential therapeutic targets.

Greene CM, Gaughan KP.

Curr Opin Pulm Med. 2013 Jan;19(1):66-72. doi: 10.1097/MCP.0b013e32835a5bc8. Review.

PMID:
23095468
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk